Skip to main content

Together we are beating cancer

Donate now

Cancer News

The latest news, analysis and opinion from Cancer Research UK

Screening and early diagnosis

Showing 12 out of 28 results
Sânziana Foia in the lab with an image of Papcup, the new HPV test she has designed for cervical screening, on a laptop.

Sânziana Foia is developing a cervical screening device designed to detect high-risk HPV in menstrual blood within minutes. It could help remove some of the biggest barriers to cervical screening, helping many more eligible people take part.  Sânziana Foia is developing a cervical screening device designed to detect high-risk HPV in menstrual blood within minutes. It could help remove some of the biggest barriers to cervical screening, helping many more eligible people take part. 

by Sadaf Shafaghmotlagh | Analysis | 4 September 2024

4 September 2024

Stained cervical cells viewed under the microscope

More than million more women in England could take part in cervical screening over the next three years if they were offered do-it-yourself kits, according to the YouScreen trial. More than million more women in England could take part in cervical screening over the next three years if they were offered do-it-yourself kits, according to the YouScreen trial.

by Sadaf Shafaghmotlagh, Tim Gunn | News | 17 July 2024

17 July 2024

A crowd of people looking concerned on a hot day.

More UK adults are concerned about cancer than any other medical condition, and most people want to see a future where it can be diagnosed much earlier. More UK adults are concerned about cancer than any other medical condition, and most people want to see a future where it can be diagnosed much earlier.

by Tim Gunn | News | 15 July 2024

15 July 2024

A computer-generated images showing a DNA double-helix in a blood sample

Multi-cancer tests have the potential to detect multiple cancer types from a single sample. There's a lot to learn before we can use them. Multi-cancer tests have the potential to detect multiple cancer types from a single sample. There's a lot to learn before we can use them.

by Jessica Lloyd, Alice Brookes | In depth | 12 June 2024

12 June 2024

This entry is part 1 of 1 in the series Multi-cancer tests
Anna Housley and her husband Tom. The BCAN-RAY project found that Anna has an increased risk of developing breast cancer. She now gets yearly mammograms.

One year in, the research project launched in memory of Sarah Harding is identifying younger women who may have a higher breast cancer risk. One year in, the research project launched in memory of Sarah Harding is identifying younger women who may have a higher breast cancer risk.

by Tim Gunn | News | 30 May 2024

30 May 2024

A male patient with a female doctor during an appointment

Fewer middle-aged people are dying from cancer in the UK than at any point over the last 25 years, a new study from Cancer Research UK has revealed Fewer middle-aged people are dying from cancer in the UK than at any point over the last 25 years, a new study from Cancer Research UK has revealed

by Jacob Smith | News | 14 March 2024

14 March 2024

A microscope image showing cells affected by Barrett's oesophagus, a precancer that can lead to oesophageal cancer.

For oesophageal cancer awareness month, we’ve rounded up four of our articles on the latest research into oesophageal cancer diagnosis, treatment and prevention.   For oesophageal cancer awareness month, we’ve rounded up four of our articles on the latest research into oesophageal cancer diagnosis, treatment and prevention.  

by Amy Warnock | Analysis | 9 February 2024

9 February 2024

An image of a capsule sponge, a test for Barrett's oesophagus and oesophageal cancer

Our BEST4 trial will show if a capsule sponge test can be used to monitor people at high risk of oesophageal cancer. It could give the NHS a quick and simple new screening test for oesophageal cancer and save thousands of lives every year.  Our BEST4 trial will show if a capsule sponge test can be used to monitor people at high risk of oesophageal cancer. It could give the NHS a quick and simple new screening test for oesophageal cancer and save thousands of lives every year. 

by Tim Gunn | Analysis | 11 January 2024

11 January 2024

Steph Phillips, Dr Miriam Dixon-Zegeye & Professor Sarah Blagden

We're funding the UK's first precision cancer prevention trial unit. It's testing a drug that could help protect people with Li Fraumeni Syndrome, a genetic condition that can lead to a more than 90% lifetime risk of cancer, against the disease. We're funding the UK's first precision cancer prevention trial unit. It's testing a drug that could help protect people with Li Fraumeni Syndrome, a genetic condition that can lead to a more than 90% lifetime risk of cancer, against the disease.

by Tim Gunn | In depth | 19 September 2023

19 September 2023